1.180SEK-1.26%Mkt Cap: 113.48M SEKP/E: —Last update: 2026-06-01
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap113.48M SEK
Enterprise Value71.37M SEK
Revenue (TTM)13.83M SEK
Gross Profit11.52M SEK
Net Income (TTM)-43.36M SEK
Revenue/Share0.2660 SEK
Last Price1.180 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.09
PEG—
EV/EBITDA-1.86
EV/Revenue5.16
P/S8.31
P/B0.73
EPS (TTM)-0.71
EPS (Forward)-1.10
52W Range
0.906015% of range2.790
52W High2.790 SEK
52W Low0.9060 SEK
Profitability
Gross Margin1042.65%
Oper. Margin-188.10%
EBITDA Margin-277.05%
Profit Margin-3925.50%
ROE-36.77%
ROA-33.08%
Growth
Revenue Growth-14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.87M SEK
CapEx (TTM)14.09M SEK
FCF Margin-197.18%
FCF Yield-24.03%
Net Debt-43.55M SEK
Net Debt/EBITDA1.14
Balance Sheet
Debt/Equity0.03
Current Ratio3.70
Quick Ratio3.70
Book Value/Sh1.640 SEK
Cash/Share0.5120 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.8000 SEK
Target Range0.8000 SEK – 0.8000 SEK
# Analysts1
Ownership
Shares Out.96.17M
Float92.60M
Insiders48.90%
Institutions34.06%
Technical
SMA 501.171 (+0.7%)
SMA 2001.460 (-19.2%)
Beta0.38
S&P 52W Chg27.70%
Avg Vol (30d)77.66K
Avg Vol (10d)44.05K
Technical Indicators
RSI (14)54.4
MACD0.0007
MACD Signal-0.0030
MACD Hist.+0.0037
BB Upper1.249 SEK
BB Middle1.176 SEK
BB Lower1.103 SEK
BB Width12.42%
ATR (14)0.0620 SEK
Vol Ratio (20d)1.40x